← FDA Drug Approvals (Drugs@FDA)

PIMECROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2019-08-29

Drug application

FDA Application #
ANDA211769
Application type
Abbreviated New Drug Application (Generic)
Brand name
PIMECROLIMUS
Generic name
PIMECROLIMUS
Active ingredients
PIMECROLIMUS
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
GLENMARK PHARMS LTD
Manufacturer
Glenmark Pharmaceuticals Inc., USA
First approval
2019-08-29

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown